When a Brain Tumor Requires Specialized Expertise, We Can Help.
Whether you’re treating glioblastoma, brain metastases, meningioma, acoustic neuroma or another complex brain or skull base tumor, we can be your trusted collaborator.
Schedule an introductory meeting with one of our neuro-oncology or neurosurgical oncology specialists. For optimal convenience, choose from virtual or in-person meetings to learn how we can collaborate with you and help your patients access advanced treatments and clinical trials.
When you connect with our team, you have access to:
- Physician-to-physician consultation pathways
- Multidisciplinary tumor board expertise
- Leading clinical trials
- Support for complex brain and skull base tumors
- Coordinated care that keeps you involved
Complete the form to schedule your introductory conversation.
All Rights Reserved. ©2026 by Northwestern Medicine® and Northwestern Memorial HealthCare.
Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University.
Northwestern Medicine® | 251 E Huron Street | Chicago, IL 60611 | nm.org
LOU & JEAN MALNATI BRAIN TUMOR INSTITUTE
Northwestern Memorial Hospital is proud to be ranked No. 2 in the nation in neurology and neurosurgery and No. 8 in the nation for cancer by U.S. News & World Report, one of the hospital's six specialties in the top five nationally.
SCHEDULE AN INTRODUCTORY MEETING
Connect with a Northwestern Medicine brain tumor specialist to discuss referral pathways, clinical trials and how we can support your patients. Complete the form below to schedule a virtual or in-person meeting.
PHYSICIAN LEADERS
MAKE THE NO. 2 NEURO PROGRAM YOUR NO. 1 CHOICE FOR BRAIN TUMOR REFERRALS.
Northwestern
Memorial Hospital
Our program includes nationally recognized specialists with expertise in difficult-to-treat brain tumors.
Why Connect With Us?
When a patient requires specialized expertise, having the right referral relationship in place can make all the difference.
Northwestern Memorial Hospital is proud to be ranked No. 2 in the nation in neurology and neurosurgery and No. 8 in the nation for cancer by U.S. News & World Report, 2026 – 2027. Those achievements reflect not just our drive to deliver excellent outcomes, but expertise built from deep experience on our field’s frontier.
We collaborate with physicians across the country to provide access to advanced diagnostics, multidisciplinary expertise, innovative treatments and clinical trials for patients with complex neurological cancers.
A short introductory meeting can help establish a direct connection with our team before a complex case arises.
During the conversation, we can discuss:
- Referral pathways for brain and skull base tumors
- Neuro-oncology and neurosurgical oncology services
- Clinical trial opportunities for your patients
- Tumor board reviews and case consultation options
- Strategies for coordinated care between our teams
- Resources available to help support your patients and practice
After you submit the form, we’ll contact you to coordinate a virtual or in-person meeting.
Rimas Lukas, MD
Vice Chair, Outpatient Neurology
Neuro-oncology
Stephen Magill, MD, PhD
Director, Meningioma Program
Neurosurgical Oncology and Skull Base Surgery
Adam Sonabend, MD
Director, Translational Neuro-oncology
Neurosurgical Oncology
Dr. Lukas specializes in the medical management of glioblastoma and primary and metastatic brain tumors. He has extensive experience connecting patients with emerging therapies and clinical trials. He works closely with referring physicians to develop individualized treatment strategies.
Dr. Magill specializes in skull base and other complex intracranial tumors, including meningiomas and acoustic neuromas, and tumors affecting the eye, orbit and optic nerves. As part of an integrated skull base team, he collaborates with specialists across multiple fields to achieve the best possible outcomes while preserving neurological function.
Dr. Sonabend focuses on glioblastoma and other primary brain tumors, with expertise in advanced tumor resection techniques for challenging cases. He also serves as a principal investigator on clinical trials evaluating novel therapies for glioblastoma.
WHY NORTHWESTERN MEDICINE?
- One of the nation's leading brain tumor programs: Our neuro-oncology program includes renowned specialists dedicated to treating rare, complex and hard-to-manage brain tumors.
- Multidisciplinary tumor board reviews: Dedicated brain tumor boards meet three times a week. Many cases can be reviewed before patient travel, helping streamline care decisions.
- Access to innovative therapies: Our physician-scientists have helped develop and advance breakthrough options for patients with brain tumors and neurological cancers.
- Clinical trials and research leadership: As part of the NCI-designated Robert H. Lurie Comprehensive Cancer Center, we offer access to clinical trials and emerging therapies not widely available at other institutions.
- Advanced neuropathology expertise: We provide state-of-the-art neuropathology services, including advanced molecular diagnostics and methylation profiling that can help improve diagnostic precision and treatment planning.
- A collaborative referral approach: We work closely with referring physicians to share expertise while maintaining strong communication at every step.
ABOUT NORTHWESTERN MEDICINE LOU & JEAN MALNATI BRAIN TUMOR INSTITUTE
Northwestern Medicine Lou & Jean Malnati Brain Tumor Institute is among the nation's leading centers for brain tumor care, research and innovation.
Our specialists bring together expertise in neuro-oncology, neurosurgery, radiation oncology, neuropathology, neuroradiology and supportive care to provide comprehensive treatment for primary and metastatic brain tumors.
Through leading-edge research, clinical trial, and multidisciplinary collaboration, we’re advancing the brain tumor medicine of tomorrow for patients today.
